top of page

Neuralink Projects USD 1 Billion Annual Revenue by 2031 with Brain Implant Expansion

  • Jul 24, 2025
  • 1 min read

Neuralink, the brain implant company founded by Elon Musk, is targeting annual revenue of at least USD 1 billion by 2031, according to investor documents cited by Bloomberg News.


Transparent head with highlighted brain beside a smartphone showing a tweet about a clinical trial by Neuralink. Background is soft beige.
Credit: NEURALINK

The company plans to implant its chips in 20,000 people each year and operate five large clinics within six years.


Black oval device with a ribbon cable on a white background, featuring a printed arrow-like symbol in white.
Credit: NEURALINK

Neuralink aims to offer three versions of its brain implant: Telepathy, for communication between the brain and machines; Blindsight, for restoring vision; and Deep, for treating tremors and Parkinson’s disease.


The company expects to receive regulatory approval for its Telepathy device by 2029. It plans to perform 2,000 surgeries annually with the device, generating USD 100 million in revenue.


By 2030, Neuralink anticipates launching Blindsight, increasing surgeries to 10,000 per year and generating over USD 500 million in revenue.


Founded in 2016, Neuralink has raised about USD 1.3 billion from investors and is valued at approximately USD 9 billion, according to PitchBook.


In May, the U.S. Food and Drug Administration granted a "breakthrough" designation to Neuralink’s speech restoration device. A similar designation was given last year for its vision-restoring device.


Neuralink raised USD 650 million in its latest funding round last month. The company began human trials in 2024 after addressing safety concerns that led to an initial rejection by the FDA in 2022.


Currently, five patients with severe paralysis are using Neuralink’s device to control digital and physical tools using only their thoughts.

  • Neuralink targets USD 1 billion in annual revenue by 2031

  • Plans include 20,000 implants per year and five large clinics

  • Three devices in development: Telepathy, Blindsight, and Deep


Source: REUTERS

 
 
 

Comments

As Asia becomes the fastest growing tech adoption region, biz360tv is committed to keeping readers up to date on the latest developments in business technology news in Asia and beyond.

While we use new technologies such as AI to improve our storytelling capabilities, our team carefully select the stories and topics to cover and goes through fact-checking, editing, and oversight before publication. Please contact us at editorial@tech360.tv if you notice any errors or inaccuracies. Your feedback will be vital in ensuring that our articles are accurate for all of our readers.

bottom of page